ArticleAsia Oceania journal of nuclear medicine & biology2025
Feasibility of shortened scan acquisition time with IQ-SPECT technology using SMARTZOOM(TM) collimator in myocardial perfusion imaging.
Article in Asia Oceania journal of nuclear medicine & biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: IQ-SPECT technology uses cardiac-specific SMARTZOOM(TM) collimator that can reduce the time required to acquire myocardial perfusion images to half (14 seconds/view) of a standard SPECT procedure. This study aimed to further shorten the scan acquisition time (7 seconds/view) using the SMARTZOOM(TM) collimator without compromising the image quality. Methods: This prospective observational study involved 50 patients (39 men and 11 women) who underwent myocardial perfusion studies using the SMARTZOOM(TM) collimator. The scans were acquired in 7 seconds/view (Group A) and 14 seconds/view (Group B). Attenuation-corrected (AC), non-attenuation-corrected (NAC), and polar maps were generated for both groups using the QGS/QPS software. The groups were qualitatively and quantitatively compared in terms of image quality, relative uptake score, summed scores, total perfusion deficit, and left ventricular ejection fraction (LVEF). Results: The image quality of both groups was comparable in the AC studies, whereas Group B was superior to Group A in the NAC studies. All images exhibited an image quality score of ≥3, which suggested adequate image quality. The mean LVEF values were 62.16 and 64.34 in Groups A and B, respectively (p-value 0.326). A strong positive correlation was observed between the two datasets (Pearson's r=0.59). The mean summed score in the AC images was 7.5 in both groups (p-value 0.49), and in the NAC images, the scores were 7.68 in Group A and 7.46 in Group B (p-value 0.46). The mean total perfusion deficits calculated using the 17-segment models were 11% and 16% in Group A and Group B, respectively, for the AC images (p-value 0.143) and 11.2% and 16.5% in Group A and Group B, respectively, for the NAC images (p-value 0.135). Significant differences were not noted in the calculation of the relative uptake score in segments 1- 17 for the AC and NAC images in Groups A and B. Conclusion: The findings from this study indicate that further shortening of the scan acquisition time to 7 seconds/view is possible in myocardial perfusion imaging using the SMARTZOOM(TM) collimator without compromising the scan quality and the results, thus improving patient comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.